White House Chief of Staff Susie Wiles announced on September 16, 2026, that she is cancer-free following six months of treatment for early-stage breast cancer. The update came after pathology results from a medical appointment at the Mayo Clinic showed no residual cancer.
Wiles, 69, was first diagnosed in mid-March 2026. At the time, she noted that nearly one in eight women in the United States will face a similar diagnosis in their lifetime, citing American Cancer Society statistics. Despite the demanding nature of her role, Wiles continued to serve as White House Chief of Staff throughout her treatment.
In an op-ed published September 27, 2026, Wiles reflected on the strain of balancing her medical care with her executive duties. “The balance was not easy. There were days when strength just meant fighting the disease with all I had,” she wrote.
She credited her focus on public service as a source of stability during her recovery. “It reminded me that I was still myself – and that my life was about more than my disease,” Wiles said.
Gratitude and Support
Wiles expressed deep gratitude to President Donald Trump, her daughters, and her medical team for their encouragement. President Trump had publicly praised Wiles’ resilience, calling her “one of the strongest people I know” and noting her “excellent” prognosis at the time of her diagnosis.
The announcement drew support from administration officials and lawmakers. Vice President JD Vance called the news an “answer to prayer,” while Sen. Rick Scott described it similarly.
Medical Details and Prognosis
Wiles has not publicly disclosed the exact stage of her cancer, tumor subtype, surgical procedure, or specific treatments she received. However, early-stage breast cancer (stages 0-II) generally carries high five-year survival rates above 90-99%, depending on factors like tumor size and lymph node involvement.
According to medical experts, common treatments for early-stage breast cancer include lumpectomy or mastectomy followed by radiation, hormone therapy, or chemotherapy. These treatments are personalized by oncologists based on individual pathology results.
Continuing Service
Throughout her treatment, Wiles maintained her position as the first female White House Chief of Staff, a role she assumed following President Trump’s 2024 election victory. Her political career stretches back to former President Ronald Reagan’s 1980 presidential campaign, where she worked as a campaign scheduler.
Wiles also ran Sen. Rick Scott’s successful 2010 campaign for Florida governor and briefly managed former Utah Gov. Jon Huntsman’s 2012 presidential campaign. She previously served as co-campaign manager for Trump’s 2024 presidential campaign before being promoted to chief of staff.
Broader Impact and Awareness
Wiles’ high-profile disclosure has contributed to ongoing conversations about breast cancer awareness and early detection. Medical professionals note that celebrity and public figure disclosures often lead to increased screening rates, with studies showing short-term increases of 10-20% following such announcements.
For women over 65, breast cancer incidence rises sharply, with approximately a one in 15 lifetime risk. About 80% of cases in this demographic are hormone-positive, with survival rates exceeding 90% when caught early through regular screenings.
Medical experts emphasize the importance of annual mammograms for women aged 40 and older, as recommended by major health organizations including the National Comprehensive Cancer Network (NCCN) and the American Society of Clinical Oncology (ASCO).
Looking Forward
Wiles indicated that while she has completed the most intensive phase of her treatment, the next stage will require a serious commitment to rebuilding her strength. She remains committed to continuing her work advancing President Trump’s agenda.
“I will always be grateful to President Donald Trump for the kindness and compassion he showed me while I was undergoing treatment,” Wiles wrote in her op-ed.
About Breast Cancer
Breast cancer is the most common form of cancer among women in the United States, excluding skin cancers. According to the American Cancer Society, more than 380,000 American women are diagnosed with some form of breast cancer each year.
Death rates from breast cancer have fallen by 44% since 1989, largely due to earlier detection through screening and improvements in treatment. The overall five-year survival rate for breast cancer in the U.S. is now 90%.
Risk factors for breast cancer include age, genetic mutations (particularly BRCA1 and BRCA2), family history, and hormonal factors. Lifestyle factors such as regular exercise, maintaining a healthy weight, limiting alcohol consumption, and not smoking can help reduce risk.
Early detection remains the most effective tool in combating breast cancer. Mammograms can detect tumors before they can be felt, often before they have spread to lymph nodes or other parts of the body. Women at average risk should begin annual mammograms at age 40, though individual recommendations may vary based on personal and family medical history.
